Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

FIB/SEM technology and high-throughput 3D reconstruction of dendritic spines and synapses in GFP-labeled adult-generated neurons

  • Bosch, Carles
  • Martínez, Albert
  • Masachs, Nuria
  • Teixeira, Cátia M.
  • Fernaud, Isabel
  • Ulloa, Fausto
  • Pérez-Martínez, Esther
  • Lois, Carlos
  • Comella i Carnicé, Joan Xavier|||0000-0002-6218-0786
  • DeFelipe, Javier
  • Merchán-Pérez, Angel
  • Soriano García, Eduardo
  • Comella i Carnicé, Joan Xavier|||0000-0002-6218-0786
The fine analysis of synaptic contacts is usually performed using transmission electron microscopy (TEM) and its combination with neuronal labeling techniques. However, the complex 3D architecture of neuronal samples calls for their reconstruction from serial sections. Here we show that focused ion beam/scanning electron microscopy (FIB/SEM) allows efficient, complete, and automatic 3D reconstruction of identified dendrites, including their spines and synapses, from GFP/DAB-labeled neurons, with a resolution comparable to that of TEM. We applied this technology to analyze the synaptogenesis of labeled adult-generated granule cells (GCs) in mice. 3D reconstruction of dendritic spines in GCs aged 3-4 and 8-9 weeks revealed two different stages of dendritic spine development and unexpected features of synapse formation, including vacant and branched dendritic spines and presynaptic terminals establishing synapses with up to 10 dendritic spines. Given the reliability, efficiency, and high resolution of FIB/SEM technology and the wide use of DAB in conventional EM, we consider FIB/SEM fundamental for the detailed characterization of identified synaptic contacts in neurons in a high-throughput manner.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Renal Biopsy in Type 2 Diabetic Patients

  • Espinel Garuz, Eugenia
  • Agraz Pamplona, Irene|||0000-0002-4223-6834
  • Ibernon, Meritxell
  • Ramos Terrades, Natalia|||0000-0001-9832-326X
  • Fort Ros, Joan
  • Seron, Daniel|||0000-0003-2054-653X
The majority of diabetic patients with renal involvement are not biopsied. Studies evaluating histological findings in renal biopsies performed in diabetic patients have shown that approximately one third of the cases will show pure diabetic nephropathy, one third a non-diabetic condition and another third will show diabetic nephropathy with a superimposed disease. Early diagnosis of treatable non-diabetic diseases in diabetic patients is important to ameliorate renal prognosis. The publication of the International Consensus Document for the classification of type 1 and type 2 diabetes has provided common criteria for the classification of diabetic nephropathy and its utility to stratify risk for renal failure has already been demonstrated in different retrospective studies. The availability of new drugs with the potential to modify the natural history of diabetic nephropathy has raised the question whether renal biopsies may allow a better design of clinical trials aimed to delay the progression of chronic kidney disease in diabetic patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reelin Regulates the Maturation of Dendritic Spines, Synaptogenesis and Glial Ensheathment of Newborn Granule Cells

  • Bosch, Carles
  • Masachs, Nuria
  • Exposito-Alonso, David
  • Martínez, Albert
  • Teixeira, Cátia M.
  • Fernaud, Isabel
  • Pujadas, Lluís
  • Ulloa, Fausto
  • Comella i Carnicé, Joan Xavier|||0000-0002-6218-0786
  • DeFelipe, Javier
  • Merchán-Pérez, Angel
  • Soriano García, Eduardo
The extracellular protein Reelin has an important role in neurological diseases, including epilepsy, Alzheimer's disease and psychiatric diseases, targeting hippocampal circuits. Here we address the role of Reelin in the development of synaptic contacts in adult-generated granule cells (GCs), a neuronal population that is crucial for learning and memory and implicated in neurological and psychiatric diseases. We found that the Reelin pathway controls the shapes, sizes, and types of dendritic spines, the complexity of multisynaptic innervations and the degree of the perisynaptic astroglial ensheathment that controls synaptic homeostasis. These findings show a pivotal role of Reelin in GC synaptogenesis and provide a foundation for structural circuit alterations caused by Reelin deregulation that may occur in neurological and psychiatric disorders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification and characterization of new isoforms of human fas apoptotic inhibitory molecule (FAIM)

  • Coccia, Elena|||0000-0002-9849-2423
  • Calleja Yagüe, Isabel|||0000-0003-3116-2873
  • Planells Ferrer, Laura
  • Sanuy, Blanca
  • Sanz, Belen
  • López-Soriano, Joaquín
  • Moubarak, Rana S.|||0000-0003-2096-1258
  • Munell Casadesus, Francina|||0000-0001-8580-2819
  • Barneda Zahonero, Bruna|||0000-0002-6557-5222
  • Comella i Carnicé, Joan Xavier|||0000-0002-6218-0786
  • Pérez-García, M. Jose|||0000-0001-9014-7986
Fas Apoptosis Inhibitory Molecule (FAIM) is an evolutionarily highly conserved death receptor antagonist, widely expressed and known to participate in physiological and pathological processes. Two FAIM transcript variants have been characterized to date, namely FAIM short (FAIM-S) and FAIM long (FAIM-L). FAIM-S is ubiquitously expressed and serves as an anti-apoptotic protein in the immune system. Furthermore, in neurons, this isoform promotes NGF-induced neurite outgrowth through NF-кB and ERK signaling. In contrast FAIM-L is found only in neurons, where it exerts anti-apoptotic activity against several stimuli. In addition to these two variants, in silico studies point to the existence of two additional isoforms, neither of which have been characterized to date. In this regard, here we confirm the presence of these two additional FAIM isoforms in human fetal brain, fetal and adult testes, and placenta tissues. We named them FAIM-S_2a and FAIM-L_2a since they have the same sequence as FAIM-S and FAIM-L, but include exon 2a. PCR and western blot revealed that FAIM-S_2a shows ubiquitous expression in all the tissues and cellular models tested, while FAIM-L_2a is expressed exclusively in tissues of the nervous system. In addition, we found that, when overexpressed in non-neuronal cells, the splicing factor nSR100 induces the expression of the neuronal isoforms, thus identifying it as responsible for the generation of FAIM-L and FAIM-L_2a. Functionally, FAIM-S_2a and FAIM-L_2a increased neurite outgrowth in response to NGF stimulation in a neuronal model. This observation thus, supports the notion that these two isoforms are involved in neuronal differentiation. Furthermore, subcellular fractionation experiments revealed that, in contrast to FAIM-S and FAIM-L, FAIM-S_2a and FAIM-L_2a are able to localize to the nucleus, where they may have additional functions. In summary, here we report on two novel FAIM isoforms that may have relevant roles in the physiology and pathology of the nervous system.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

SIVA-1 regulates apoptosis and synaptic function by modulating XIAP interaction with the death receptor antagonist FAIM-L

  • Coccia, Elena|||0000-0002-9849-2423
  • Planells Ferrer, Laura
  • Badillos Rodríguez, Raquel|||0000-0002-8257-1784
  • Pascual Sánchez, Marta|||0000-0002-2621-650X
  • Segura, Miguel F.|||0000-0003-0916-3618
  • Fernández-Hernández, Rita
  • López-Soriano, Joaquín
  • Gari, Eloi|||0000-0002-3505-4901
  • Soriano García, Eduardo
  • Barneda Zahonero, Bruna|||0000-0002-6557-5222
  • Moubarak, Rana S.|||0000-0003-2096-1258
  • Pérez-García, M. Jose|||0000-0001-9014-7986
  • Comella i Carnicé, Joan Xavier|||0000-0002-6218-0786
The long isoform of Fas apoptosis inhibitory molecule (FAIM-L) is a neuron-specific death receptor antagonist that modulates apoptotic cell death and mechanisms of neuronal plasticity. FAIM-L exerts its antiapoptotic action by binding to X-linked inhibitor of apoptosis protein (XIAP), an inhibitor of caspases, which are the main effectors of apoptosis. XIAP levels are regulated by the ubiquitin-proteasome pathway. FAIM-L interaction with XIAP prevents the ubiquitination and degradation of the latter, thereby allowing it to inhibit caspase activation. This interaction also modulates non-apoptotic functions of caspases, such as the endocytosis of AMPA receptor (AMPAR) in hippocampal long-term depression (LTD). The molecular mechanism of action exerted by FAIM-L is unclear since the consensus binding motifs are still unknown. Here, we performed a two-hybrid screening to discover novel FAIM-L-interacting proteins. We found a functional interaction of SIVA-1 with FAIM-L. SIVA-1 is a proapoptotic protein that has the capacity to interact with XIAP. We describe how SIVA-1 regulates FAIM-L function by disrupting the interaction of FAIM-L with XIAP, thereby promoting XIAP ubiquitination, caspase-3 activation and neuronal death. Furthermore, we report that SIVA-1 plays a role in receptor internalization in synapses. SIVA-1 is upregulated upon chemical LTD induction, and it modulates AMPAR internalization via non-apoptotic activation of caspases. In summary, our findings uncover SIVA-1 as new functional partner of FAIM-L and demonstrate its role as a regulator of caspase activity in synaptic function.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cyclophilins A and B oppositely regulate renal tubular epithelial cell phenotype

  • Sarró, Eduard|||0000-0001-7723-2916
  • Durán, Mónica|||0000-0002-6513-5948
  • Rico, Ana
  • Bou-Teen, Diana|||0000-0003-3181-3824
  • Fernández-Majada, Vanesa
  • Croatt, Anthony J.
  • Nath, Karl A.
  • Salcedo, Maria-Teresa|||0000-0002-4822-5060
  • Gundelach, Justin H.
  • Batlle, Daniel
  • Bram, Richard J.
  • Meseguer Navarro, Anna|||0000-0003-3833-2249
Restoration of kidney tubular epithelium following sublethal injury sequentially involves partial epithelial-mesenchymal transition (pEMT), proliferation, and further redifferentiation into specialized tubule epithelial cells (TECs). Because the immunosuppressant cyclosporine-A produces pEMT in TECs and inhibits the peptidyl-prolyl isomerase (PPIase) activity of cyclophilin (Cyp) proteins, we hypothesized that cyclophilins could regulate TEC phenotype. Here we demonstrate that in cultured TECs, CypA silencing triggers loss of epithelial features and enhances transforming growth factor β (TGF β)-induced EMT in association with upregulation of epithelial repressors Slug and Snail. This pro-epithelial action of CypA relies on its PPIase activity. By contrast, CypB emerges as an epithelial repressor, because CypB silencing promotes epithelial differentiation, prevents TGF β -induced EMT, and induces tubular structures in 3D cultures. In addition, in the kidneys of CypB knockout mice subjected to unilateral ureteral obstruction, inflammatory and pro-fibrotic events were attenuated. CypB silencing/knockout leads to Slug, but not Snail, downregulation. CypB support of Slug expression depends on its endoplasmic reticulum location, where it interacts with calreticulin, a calcium-buffering chaperone related to Slug expression. As CypB silencing reduces ionomycin-induced calcium release and Slug upregulation, we suggest that Slug expression may rely on CypB modulation of calreticulin-dependent calcium signaling. In conclusion, this work uncovers new roles for CypA and CypB in modulating TEC plasticity and identifies CypB as a druggable target potentially relevant in promoting kidney repair.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Kidney Androgen-Regulated Protein (KAP) Transgenic Mice Are Protected Against High-Fat Diet Induced Metabolic Syndrome

  • de Quixano, Beatriz Bardaji
  • Villena, Josep A.|||0000-0002-2200-2985
  • Aranda Martín, Miguel|||0000-0002-4033-641X
  • Brils, Gemma
  • Cuevas Alcalá, Antoni
  • Hespel, Théana
  • Lekuona, Haizea
  • Suárez, Cristina|||0000-0002-0502-5528
  • Tornavaca, Olga
  • Meseguer Navarro, Anna|||0000-0003-3833-2249
Metabolic Syndrome (MS) is reaching epidemic proportions with significant social and economical burden worldwide. Since the molecular basis of MS remains poorly defined, we investigated the impact of KAP, a kidney specific androgen-regulated gene, in the development of high fat-diet (hfd)-induced MS. Tg mice overexpressing KAP specifically in proximal tubule cells of the kidney exhibited reduced body weight and lower liver and adipose tissue weight compared to control littermates when fed a hfd. KAP Tg mice showed diminished adipocyte hypertrophy and reduced hepatic steatosis, significantly correlating with expression of relevant molecular markers and lower lipid content in liver. KAP transgenic were protected from hfd-induced insulin resistance, increased blood pressure and exhibited lower IL-6 serum levels and diminished expression of inflammatory markers in the adipose. Moreover, KAP was localized in the secretory pathway of proximal tubule cells and it is released to the extracellular media, preventing IL-6 induction and STAT-3 activation upon TNFα stimulation. We conclude that KAP, which might act as a hormone-like product in extra-renal tissues, protects Tg mice against hfd-induced MS by preventing inflammatory related events that are mediated, in part, through the IL-6 pathway.
Dipòsit Digital de Documents de la UAB
Publication Contribución de congreso (ConferenceOutput)

Ischaemic conditioning and targeting reperfusion injury, a 30 year voyage of discovery

  • Hausenloy, Derek J.
  • Barrabés, José A.|||0000-0001-7062-6277
  • Bøtker, Hans Erik|||0000-0001-6358-8962
  • Davidson, Sean M.|||0000-0001-5182-4980
  • Di Lisa, Fabio
  • Downey, James
  • Engstrom, Thomas
  • Ferdinandy, Péter|||0000-0002-6424-6806
  • Carbrera-Fuentes, Hector A.
  • Heusch, Gerd
  • Ibañez, Borja|||0000-0002-5036-254X
  • Iliodromitis, Efstathios K.
  • Inserte, Javier|||0000-0003-2283-3591
  • Jennings, Robert
  • Kalia, Neena
  • Kharbanda, Rajesh
  • Lecour, Sandrine|||0000-0003-1942-8974
  • Marber, Michael
  • Miura, Tetsuji|||0000-0001-5024-7085
  • Ovize, Michel
  • Perez-Pinzon, Miguel A.
  • Piper, Hans Michael
  • Przyklenk, Karin
  • Schmidt, Michael Rahbek
  • Redington, Andrew
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Vilahur, Gemma|||0000-0002-2828-8873
  • Vinten-Johansen, Jakob
  • Yellon, Derek|||0000-0001-7791-9320
  • García-Dorado, David|||0000-0002-1126-1279
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Interplay between Inflammation and Fibrosis in Kidney Transplantation

  • Torres, Irina B.|||0000-0003-3304-0810
  • Moreso, Francesc|||0000-0002-7267-3963
  • Sarró, Eduard|||0000-0001-7723-2916
  • Meseguer Navarro, Anna|||0000-0003-3833-2249
  • Seron, Daniel|||0000-0003-2054-653X
Serial surveillance renal allograft biopsies have shown that early subclinical inflammation constitutes a risk factor for the development of interstitial fibrosis. More recently, it has been observed that persistent inflammation is also associated with fibrosis progression and chronic humoral rejection, two histological conditions associated with poor allograft survival. Treatment of subclinical inflammation with steroid boluses prevents progression of fibrosis and preserves renal function in patients treated with a cyclosporine-based regimen. Subclinical inflammation has been reduced after the introduction of tacrolimus based regimens, and it has been shown that immunosuppressive schedules that are effective in preventing acute rejection and subclinical inflammation may prevent the progression of fibrosis and chronic humoral rejection. On the other hand, minimization protocols are associated with progression of fibrosis, and noncompliance with the immunosuppressive regime constitutes a major risk factor for chronic humoral rejection. Thus, adequate immunosuppressive treatment, avoiding minimization strategies and reinforcing educational actions to prevent noncompliance, is at present an effective approach to combat the progression of fibrosis.